Wednesday, August 26, 2026

Broadcom Drops 19.5% in Five Days as 2-Year Treasury Yield Hits 16-Month High

Tech stocks suffered a broad selloff from June 3–5, 2026, with Broadcom losing 19.5%, NVIDIA falling 6%, and leveraged ETF FNGU collapsing 22%. The US 2-year Treasury yield spiked to a 16-month high on June 5, pointing to rate pressure rather than deteriorating AI fundamentals as the primary driver. Dell's $24 billion in Q1 AI server bookings and raised full-year guidance reinforce that underlying demand remains intact.

LM Salvado
LM Salvado

June 9, 2026

Broadcom Drops 19.5% in Five Days as 2-Year Treasury Yield Hits 16-Month High
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Broadcom fell 19.5% over June 3–5, 2026, even as the company raised its Q3 FY26 AI semiconductor guidance.1 NVIDIA dropped 6% on June 5 alone.1 Meta shed 6% over the same stretch. The leveraged FNGU ETF — tracking mega-cap tech — collapsed 22% across the five-day window.1

The US 2-year Treasury yield spiked to a 16-month high on June 5.1 That timing is central to understanding the selloff. Rate-sensitive growth stocks reprice sharply when short-end yields surge, regardless of underlying business performance.

Broadcom's guidance raise makes the stock decline harder to explain through an AI demand lens. If customers were pulling back on AI chip orders, guidance would have moved the other way. Instead, the company signaled stronger-than-expected AI semiconductor revenue ahead while the stock cratered.

NVIDIA faces the same disconnect. AI infrastructure spending signals remained positive through the period, yet shares fell in line with the broader tech selloff. When high-multiple growth stocks fall in unison on a single macro data point — a bond yield print — the rate sensitivity explanation gains weight over sector-specific deterioration.

Dell's Q1 results add further evidence that AI demand has not slowed. The company reported $24 billion in AI server order bookings for the quarter and raised its full-year revenue guidance to approximately $60 billion.1 Order pipelines of that size do not form during a genuine AI investment pullback.

The distinction matters for positioning. A rate-driven selloff is mean-reverting if yields stabilize or fall. A fundamentals-driven selloff — customers canceling AI infrastructure budgets — would require earnings revisions downward and a longer recovery timeline. The current evidence points toward the former.

AI earnings revisions across the sector have not turned negative. Until they do, steep price declines in AI-exposed stocks during yield spikes are more likely to represent valuation compression than business deterioration. Traders pricing in a structural AI slowdown on this data are reading the signal wrong.

In this story · Knowledge Files

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Network, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com